Nebivolol Krka

Nebivolol, the active ingredient in Nebivolol Krka, is a beta blocker presented as an oral tablet for oral use. It treats hypertension and heart failure in adult patients. GNH USA supplies Nebivolol Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nebivolol is a selective β1‑adrenergic antagonist used in cardiovascular disease management. - Hypertension: lowers systolic and diastolic blood pressure by reducing cardiac output and promoting vasodilation. - Heart failure: improves left‑ventricular ejection fraction and reduces symptoms in chronic heart failure. - Cardiovascular risk reduction: contributes to lower incidence of cardiovascular events in patients with high blood pressure.

Nebivolol may cause a range of adverse reactions.

Common Side Effects: - Headache: mild to moderate pain often occurring early in therapy. - Dizziness: sensation of light‑headedness, especially when standing quickly. - Fatigue: feeling unusually tired or weak. - Nausea: mild stomach upset or queasiness.

Serious or Rare Side Effects: - Severe bradycardia: markedly reduced heart rate requiring medical attention. - Hypotension: dangerously low blood pressure with risk of fainting. - Heart block: impaired electrical conduction that may necessitate pacemaker placement.

Use Nebivolol with clinical vigilance in specific situations. - Renal impairment: monitor renal function and adjust therapy as needed. - Hepatic disease: exercise caution in severe liver dysfunction. - Concomitant beta‑blockers: avoid additive cardiac depression. - Abrupt discontinuation: taper gradually to prevent rebound hypertension. - Store at room temperature: keep in the original container, protect from moisture and light.

Nebivolol can interact with several drug classes.

Major Interactions (Avoid): - Non‑selective beta blockers: may cause excessive bradycardia. - Calcium‑channel blockers (verapamil, diltiazem): increase risk of AV‑block. - Clonidine: abrupt withdrawal can precipitate rebound hypertension.

Moderate Interactions (Monitor Closely):\n- Diuretics: may enhance hypotensive effect. - ACE inhibitors/ARBs: additive blood‑pressure lowering. - Antidiabetic agents: may mask hypoglycaemia symptoms.